ApoE4 Alzheimer’s Alliance Launches to Advocate for ApoE4 Patients, Urges FDA Action
WASHINGTON, April 29, 2025 /PRNewswire/ -- The ApoE4 Alzheimer's Alliance, a new patient advocacy organization, is launching to amplify the voices of individuals with the ApoE4 gene and work with